{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:40:43Z","timestamp":1792975243793,"version":"4.5.0"},"reference-count":204,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.drup.2024.101125","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T13:38:48Z","timestamp":1722951528000},"page":"101125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance"],"prefix":"10.1016","volume":"77","author":[{"given":"Daosong","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6409","key":"10.1016\/j.drup.2024.101125_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94735-y","article-title":"Interactions of platelets with circulating tumor cells contribute to cancer metastasis","volume":"11","author":"Anvari","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.drup.2024.101125_bib3","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1136\/gutjnl-2021-325272","article-title":"Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6\/AXL signalling axis","volume":"71","author":"Bellomo","year":"2022","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib4","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2017-0024","article-title":"A phase II randomized, double-blind, placebo-controlled study of simtuzumab or placebo in combination with gemcitabine for the first-line treatment of pancreatic adenocarcinoma","volume":"22","author":"Benson","year":"2017","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.drup.2024.101125_bib5","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1002\/eji.200636033","article-title":"Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance","volume":"36","author":"Berg","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.drup.2024.101125_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.745209","article-title":"Metabolic reprogramming in gastric cancer: trojan horse effect","volume":"11","author":"Bin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2024.101125_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MPA.0b013e318205e332","article-title":"Pancreatic carcinomas in a 60-year, institute-based autopsy material with special emphasis of metastatic pattern","volume":"40","author":"Blastik","year":"2011","journal-title":"Pancreas"},{"issue":"26","key":"10.1016\/j.drup.2024.101125_bib8","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.drup.2024.101125_bib9","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1158\/0008-5472.CAN-06-1560","article-title":"Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice","volume":"66","author":"Brantley-Sieders","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2024.101125_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101579","article-title":"MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications","volume":"27","author":"Bravo-V\u00e1zquez","year":"2023","journal-title":"Transl. Oncol."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca. Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40364-022-00385-1","article-title":"Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy","volume":"10","author":"Cao","year":"2022","journal-title":"Biomark. Res"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3892\/or.2015.3789","article-title":"HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer","volume":"33","author":"Cao","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-021-01326-6","article-title":"Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones","volume":"20","author":"Cayrefourcq","year":"2021","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2024.101125_bib15","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/cancers13081946","article-title":"The role of macrophages in cancer development and therapy","volume":"13","author":"Cendrowicz","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.drup.2024.101125_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1245\/s10434-006-9023-y","article-title":"Selection of patients for resection of hepatic colorectal metastases: expert consensus statement","volume":"13","author":"Charnsangavej","year":"2006","journal-title":"Ann. Surg. Oncol."},{"issue":"19","key":"10.1016\/j.drup.2024.101125_bib17","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.7150\/thno.20942","article-title":"Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2024.101125_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2815187","article-title":"HDAC8 promotes liver metastasis of colorectal cancer via inhibition of IRF1 and upregulation of SUCNR1","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"33","key":"10.1016\/j.drup.2024.101125_bib19","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1038\/s41388-020-1378-1","article-title":"SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2024.101125_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2019.09.006","article-title":"Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG\/TYMS axis in colon cancer cells","volume":"466","author":"Chen","year":"2019","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/path.5225","article-title":"Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis","volume":"247","author":"Conlon","year":"2019","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/2159-8290.CD-11-0341","article-title":"EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib","volume":"2","author":"Corcoran","year":"2012","journal-title":"Cancer Discov."},{"issue":"27","key":"10.1016\/j.drup.2024.101125_bib23","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.20.00590","article-title":"Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic","volume":"38","author":"Cutsem","year":"2020","journal-title":"Pancreat. Aden J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"issue":"6892","key":"10.1016\/j.drup.2024.101125_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.drup.2024.101125_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol."},{"issue":"7647","key":"10.1016\/j.drup.2024.101125_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature21713","article-title":"A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer","volume":"543","author":"de Sousa e Melo","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.drup.2024.101125_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib29","first-page":"146","article-title":"The extracellular matrix: its composition, function, remodeling, and role in tumorigenesis","volume":"8","author":"Dzobo","year":"2023","journal-title":"Biomimeics"},{"key":"10.1016\/j.drup.2024.101125_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.02.005","article-title":"Tumor regulation of the tissue environment in the liver","volume":"173","author":"Eggert","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"20","key":"10.1016\/j.drup.2024.101125_bib31","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/onc.2010.49","article-title":"Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis","volume":"29","author":"El Hour","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/cancers16030604","article-title":"MACC1 regulates LGR5 to promote cancer stem cell properties in colorectal cancer","volume":"16","author":"Erdem","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2024.101125_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2019.03.039","article-title":"Metastasis of pancreatic cancer: an uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells","volume":"453","author":"Fabian","year":"2019","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/acs.analchem.0c04055","article-title":"Ultrasensitive gastric cancer circulating tumor cellular CLDN18.2 RNA detection based on a molecular beacon","volume":"93","author":"Fan","year":"2021","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3892\/mmr.2014.2728","article-title":"Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cells","volume":"11","author":"Fan","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"39","key":"10.1016\/j.drup.2024.101125_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/EDBK_240837","article-title":"Mechanisms of resistance to immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients?","author":"Fares","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000511244","article-title":"Lysyl oxidase mechanisms to mediate gastrointestinal cancer progression","volume":"8","author":"Farhat","year":"2021","journal-title":"Gastrointest. Tumors"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12943-023-01713-1","article-title":"Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution","volume":"22","author":"Fleischer","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034437","article-title":"Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer","volume":"7","author":"Fujisawa","year":"2012","journal-title":"PLoS. One"},{"issue":"18","key":"10.1016\/j.drup.2024.101125_bib40","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.drup.2024.101125_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1517\/14728222.2014.934814","article-title":"LAMC2 as a therapeutic target for cancers","volume":"18","author":"Garg","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"20","key":"10.1016\/j.drup.2024.101125_bib42","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-21-0483","article-title":"Oncostatin M receptor-targeted antibodies suppress STAT3 signaling and inhibit ovarian cancer growth","volume":"81","author":"Geethadevi","year":"2021","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.drup.2024.101125_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141083","article-title":"SLIT2\/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia","volume":"131","author":"Geraldo","year":"2021","journal-title":"J. Clin. Invest"},{"issue":"16","key":"10.1016\/j.drup.2024.101125_bib44","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/cancers14163906","article-title":"Cancer-Associated Fibroblasts:Tumorigenicity and Targeting for Cancer Therapy","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1053\/j.gastro.2016.07.043","article-title":"Pancreatic premalignant lesions secrete tissue inhibitor of metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in the Liver","volume":"151","author":"Gr\u00fcnwald","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.drup.2024.101125_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat7828","article-title":"Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival","volume":"4","author":"Gast","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2024.101125_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101027","article-title":"The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance","volume":"73","author":"Gu","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"7","key":"10.1016\/j.drup.2024.101125_bib49","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41416-021-01681-7","article-title":"The CBS-H(2)S axis promotes liver metastasis of colon cancer by upregulating VEGF through AP-1 activation.","volume":"126","author":"Guo","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2024.101125_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100937","article-title":"Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance","volume":"67","author":"Guo","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2024.101125_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2022.01.002","article-title":"Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer","volume":"172","author":"Haegebaert","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","article-title":"Platelets reduce anoikis and promote metastasis by activating YAP1 signaling","volume":"8","author":"Haemmerle","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-019-0972-8","article-title":"Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer","volume":"18","author":"Ham","year":"2019","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1634\/theoncologist.2016-0479","article-title":"A phase II, randomized, double-blind, placebo-controlled study of simtuzumab in combination with FOLFIRI for the second-line treatment of metastatic KRAS mutant colorectal adenocarcinoma","volume":"22","author":"Hecht","year":"2017","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.drup.2024.101125_bib55","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-21-0933","article-title":"Liver colonization by colorectal cancer metastases requires YAP-controlled plasticity at the micrometastatic stage","volume":"82","author":"Heinz","year":"2022","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13402-017-0317-9","article-title":"Tumor cells interact with red blood cells via galectin-4 - a short report","volume":"40","author":"Helwa","year":"2017","journal-title":"Cell Oncol. (Dordr. )"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10555-024-10173-y","article-title":"Clusterin: a marker and mediator of chemoresistance in colorectal cancer","volume":"43","author":"Hlavca","year":"2024","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001367","article-title":"Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis","volume":"8","author":"Ho","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib59","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/carcin\/bgz121","article-title":"MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK\/STAT3 signaling pathway by targeting SOCS5","volume":"41","author":"Hu","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.drup.2024.101125_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100849","article-title":"New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects","volume":"64","author":"Huang","year":"2022","journal-title":"Drug Resist. Updat."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2217\/fon-2019-0748","article-title":"Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancer","volume":"16","author":"Huijberts","year":"2020","journal-title":"Future Oncol."},{"issue":"17","key":"10.1016\/j.drup.2024.101125_bib62","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/onc.2013.180","article-title":"ADAM12-cleaved ephrin-A1 contributes to lung metastasis","volume":"33","author":"Ieguchi","year":"2014","journal-title":"Oncogene"},{"issue":"35","key":"10.1016\/j.drup.2024.101125_bib63","doi-asserted-by":"crossref","first-page":"21598","DOI":"10.1073\/pnas.2008112117","article-title":"Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer","volume":"117","author":"Itatani","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.drup.2024.101125_bib65","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1158\/1078-0432.CCR-18-2959","article-title":"EPB41L5 mediates TGF\u03b2-induced metastasis of gastric cancer","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2024.101125_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110866","article-title":"ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation","volume":"111","author":"Jiang","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.drup.2024.101125_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201800038","article-title":"iTRAQ-based quantitative proteomics approach identifies novel diagnostic biomarkers that were essential for glutamine metabolism and redox homeostasis for gastric cancer","volume":"13","author":"Jiang","year":"2019","journal-title":"Proteom. Clin. Appl."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib68","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijc.25060","article-title":"Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7","volume":"127","author":"Jung","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10637-018-0598-5","article-title":"Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis","volume":"36","author":"Kang","year":"2018","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.drup.2024.101125_bib72","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cellimm.2018.03.010","article-title":"The role of hepatic macrophages in liver metastasis","volume":"330","author":"Keirsse","year":"2018","journal-title":"Cell. Immunol."},{"issue":"11","key":"10.1016\/j.drup.2024.101125_bib73","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/stem.1233","article-title":"Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells","volume":"30","author":"Kemper","year":"2012","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib74","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cancers16051056","article-title":"Pancreatic cancer treatment targeting the HGF\/c-MET pathway: the MEK inhibitor trametinib","volume":"16","author":"Kim","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2024.101125_bib75","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1101\/gad.17558811","article-title":"The dynamic nature of autophagy in cancer","volume":"25","author":"Kimmelman","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.drup.2024.101125_bib76","article-title":"Significance of lymph node metastasis in the treatment of gastric cancer and current challenges in determining the extent of metastasis","volume":"11","author":"Kinami","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2024.101125_bib77","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/j.gastro.2021.11.037","article-title":"The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis","volume":"162","author":"Kobayashi","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.59566\/IJBS.2012.8081","article-title":"Hydrogen sulfide: potent regulator of vascular tone and stimulator of angiogenesis","volume":"8","author":"K\u00f6hn","year":"2012","journal-title":"Int. J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/diagnostics10040192","article-title":"Clinical significance of circulating tumor cells in gastrointestinal carcinomas","volume":"10","author":"Konczalla","year":"2020","journal-title":"Diagnosics"},{"issue":"15","key":"10.1016\/j.drup.2024.101125_bib80","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.7150\/ijbs.87028","article-title":"The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors","volume":"19","author":"Kong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"34","key":"10.1016\/j.drup.2024.101125_bib81","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1200\/JCO.2015.63.2497","article-title":"Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer","volume":"33","author":"Kopetz","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1200\/JCO.20.01994","article-title":"Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)","volume":"39","author":"Kopetz","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2024.101125_bib83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2017.03.023","article-title":"Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer","volume":"396","author":"Koustas","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101125_bib84","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/carcin\/bgy019","article-title":"Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view","volume":"39","author":"Krishn","year":"2018","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10456-019-09698-6","article-title":"Vessel co-option and resistance to anti-angiogenic therapy","volume":"23","author":"Kuczynski","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.drup.2024.101125_bib86","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.immuni.2020.06.016","article-title":"An oncogenic alteration creates a microenvironment that promotes tumor progression by conferring a metabolic advantage to regulatory T cells","volume":"53","author":"Kumagai","year":"2020","journal-title":"Immunity"},{"issue":"Pt 1)","key":"10.1016\/j.drup.2024.101125_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semcancer.2019.06.016","article-title":"Transcription factors in SOX family: potent regulators for cancer initiation and development in the human body","volume":"67","author":"Kumar","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.drup.2024.101125_bib88","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3748\/wjg.v20.i7.1681","article-title":"CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting","volume":"20","author":"Lee","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drup.2024.101125_bib89","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2407-11-245","article-title":"FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"issue":"52","key":"10.1016\/j.drup.2024.101125_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba0759","article-title":"Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib91","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1084\/jem.20181170","article-title":"Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"issue":"24","key":"10.1016\/j.drup.2024.101125_bib92","doi-asserted-by":"crossref","first-page":"36842","DOI":"10.18632\/oncotarget.9209","article-title":"Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib93","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2024.101125_bib94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2019.10.037","article-title":"Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts","volume":"49","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s12276-023-00946-w","article-title":"MAPK4 silencing in gastric cancer drives liver metastasis by positive feedback between cancer cells and macrophages","volume":"55","author":"Li","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib96","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cac2.12130","article-title":"S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-\u03b2\/USF2 axis in colorectal cancer","volume":"41","author":"Li","year":"2021","journal-title":"Cancer Commun."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib97","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.4251\/wjgo.v16.i4.1564","article-title":"Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription","volume":"16","author":"Li","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib98","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/cas.13502","article-title":"Protocadherin-8 promotes invasion and metastasis via laminin subunit \u03b32 in gastric cancer","volume":"109","author":"Lin","year":"2018","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib99","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41467-023-36334-1","article-title":"Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy","volume":"14","author":"Linares","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.drup.2024.101125_bib100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/abbs\/gmw101","article-title":"Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer","volume":"48","author":"Liu","year":"2016","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.drup.2024.101125_bib101","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.omtn.2018.09.026","article-title":"lncRNA GAS5 reverses EMT and tumor stem cell-mediated gemcitabine resistance and metastasis by targeting miR-221\/SOCS3 iN Pancreatic Cancer","volume":"13","author":"Liu","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00280-023-04572-1","article-title":"Mechanism of cisplatin resistance in gastric cancer and associated microRNAs","volume":"92","author":"Liu","year":"2023","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib103","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1053\/j.gastro.2020.12.077","article-title":"Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-022-01696-5","article-title":"Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ymthe.2019.02.002","article-title":"miR-577 Regulates TGF-\u03b2 Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-\u03baB in Gastric Cancer","volume":"27","author":"Luo","year":"2019","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib106","first-page":"682","article-title":"Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular","volume":"11","author":"Lv","year":"2023","journal-title":"Carcinoma J. Clin. Transl. Hepatol."},{"issue":"7","key":"10.1016\/j.drup.2024.101125_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.160","article-title":"TGF-\u03b2 signaling in liver metastasis","volume":"10","author":"Marvin","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"10","key":"10.1016\/j.drup.2024.101125_bib108","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","article-title":"Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer","volume":"119","author":"Melisi","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib109","doi-asserted-by":"crossref","first-page":"9e002068","DOI":"10.1136\/jitc-2020-002068","article-title":"Safety and activity of the TGF\u03b2 receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer","volume":"9","author":"Melisi","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2024.101125_bib110","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.15252\/emmm.201404827","article-title":"Targeting the LOX\/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy","volume":"7","author":"Miller","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"10242","key":"10.1016\/j.drup.2024.101125_bib111","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2024.101125_bib112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ctrv.2018.05.010","article-title":"Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors","volume":"69","author":"Montagnani","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2024.101125_bib113","article-title":"lncRNA\/miR-29c-mediated high expression of LOX Can influence the immune status and chemosensitivity and can forecast the poor prognosis of gastric cancer","volume":"9","author":"Nai","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.drup.2024.101125_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9624760","article-title":"Macrophages as key drivers of cancer progression and metastasis","volume":"2017","author":"Nielsen","year":"2017","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s13402-018-0388-2","article-title":"Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance","volume":"41","author":"Nilendu","year":"2018","journal-title":"Cell. Oncol. (Dordr. )"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib116","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MPA.0b013e3181e6e398","article-title":"Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and\/or Chinese herbal medicine","volume":"40","author":"Ouyang","year":"2011","journal-title":"Pancreas"},{"issue":"21","key":"10.1016\/j.drup.2024.101125_bib117","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.3390\/cancers13215532","article-title":"Epithelial to mesenchymal transition: key regulator of pancreatic ductal adenocarcinoma progression and chemoresistance","volume":"13","author":"Palamaris","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.drup.2024.101125_bib118","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib119","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00018-015-2104-y","article-title":"Autophagy inhibitors","volume":"73","author":"Pasquier","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10555-021-09979-x","article-title":"The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance","volume":"40","author":"Patil","year":"2021","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/cancers14010057","article-title":"Survival benefit of resection surgery for pancreatic ductal adenocarcinoma with liver metastases: a propensity score-matched SEER database analysis","volume":"14","author":"Pausch","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib122","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1470-2045(19)30827-7","article-title":"TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial","volume":"21","author":"Pfeiffer","year":"2020","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103969","article-title":"Circulating tumor cells: Towards mechanical phenotyping of metastasis","volume":"25","author":"Peralta","year":"2022","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.drup.2024.101125_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111298","article-title":"Circulating tumor cell-blood cell crosstalk: biology and clinical relevance","volume":"40","author":"Pereira-Veiga","year":"2022","journal-title":"Cell Rep."},{"issue":"14","key":"10.1016\/j.drup.2024.101125_bib125","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.3390\/ijms22147698","article-title":"Enhanced vasculogenic capacity induced by 5-fluorouracil chemoresistance in a gastric cancer cell line","volume":"22","author":"Peri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib126","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","article-title":"Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance","volume":"19","author":"Pothuraju","year":"2020","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib127","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrurol.2013.26","article-title":"Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis.","volume":"10","author":"Qian","year":"2013","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib128","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2023.05.038","article-title":"Transforming Growth. Factor-\u03b2 blockade in pancreatic cancer enhances sensitivity to combination chemotherapy.","volume":"165","author":"Qiang","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13046-022-02499-8","article-title":"Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis","volume":"41","author":"Qiu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrgastro.2017.52","article-title":"Stem cells: two sides to cancer stem cells in colorectal cancer","volume":"14","author":"Ray","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drup.2024.101125_bib131","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/s41467-018-07505-2","article-title":"Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression","volume":"9","author":"Rice","year":"2018","journal-title":"Nat. Commun."},{"issue":"32","key":"10.1016\/j.drup.2024.101125_bib132","doi-asserted-by":"crossref","first-page":"52307","DOI":"10.18632\/oncotarget.10740","article-title":"Metastatic spread in patients with gastric cancer","volume":"7","author":"Riihim\u00e4ki","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2024.101125_bib133","first-page":"980","article-title":"Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies","volume":"2","author":"Rodriguez-Pascual","year":"2019","journal-title":"Cancer Drug Resist"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib134","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 2)","key":"10.1016\/j.drup.2024.101125_bib135","first-page":"ii144","article-title":"Treatment of liver metastases of colorectal cancer","volume":"16","author":"Rothbarth","year":"2005","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.drup.2024.101125_bib136","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"issue":"45","key":"10.1016\/j.drup.2024.101125_bib137","doi-asserted-by":"crossref","first-page":"73725","DOI":"10.18632\/oncotarget.12455","article-title":"Role of BCL9L in transforming growth factor-\u03b2 (TGF-\u03b2)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer","volume":"7","author":"Sannino","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib138","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"Suppl 2 (Suppl 2)","key":"10.1016\/j.drup.2024.101125_bib139","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000435814","article-title":"Novel holistic approaches for overcoming therapy resistance in pancreatic and colon cancers","volume":"25","author":"Sarkar","year":"2016","journal-title":"Med. Princ. Pract."},{"issue":"22","key":"10.1016\/j.drup.2024.101125_bib140","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-17-0895","article-title":"Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer","volume":"23","author":"Scurr","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2024.101125_bib141","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/ijms23010488","article-title":"The impact of the microbiome on resistance to cancer treatment with chemotherapeutic agents and immunotherapy","volume":"23","author":"Sevcikova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib142","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib143","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s12015-022-10498-7","article-title":"Targeting redundant ROBO1 and SDF-1 pathways prevents adult hemangioblast derived-EPC and CEC activity effectively blocking tumor neovascularization","volume":"19","author":"Shenoy","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"issue":"7","key":"10.1016\/j.drup.2024.101125_bib144","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/nar\/gkq1030","article-title":"Characterization of Aquifex aeolicus ribonuclease III and the reactivity epitopes of its pre-ribosomal RNA substrates","volume":"39","author":"Shi","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.drup.2024.101125_bib145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","article-title":"Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states","volume":"39","author":"Simeonov","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib146","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/1541-7786.MCR-16-0337","article-title":"Potent EMT and CSC Phenotypes are induced by oncostatin-M iN Pancreatic Cancer","volume":"15","author":"Smigiel","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.drup.2024.101125_bib147","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3390\/cancers15112912","article-title":"Chemo-immunotherapy: a new trend in cancer treatment","volume":"15","author":"Sordo-Bahamonde","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2024.101125_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1016646","article-title":"Mechanism and strategies of immunotherapy resistance in colorectal cancer","volume":"13","author":"Shan","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib149","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"7745","key":"10.1016\/j.drup.2024.101125_bib150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","article-title":"Neutrophils escort circulating tumour cells to enable cell cycle progression","volume":"566","author":"Szczerba","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib151","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41419-021-03565-3","article-title":"CircRNA circ_0124554 blocked the ubiquitination of AKT promoting the skip lymphovascular invasion on hepatic metastasis in colorectal cancer","volume":"12","author":"Tang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib152","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical","volume":"19","author":"Tempero","year":"2021","journal-title":"Pract. Guidel. Oncol. J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib153","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4","volume":"1","author":"Todaro","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.drup.2024.101125_bib154","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann. Oncol."},{"issue":"Pt 2)","key":"10.1016\/j.drup.2024.101125_bib155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcancer.2018.01.009","article-title":"Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy","volume":"52","author":"van Dam","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.drup.2024.101125_bib156","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb2048","article-title":"Wnt activity defines colon cancer stem cells and is regulated by the microenvironment","volume":"12","author":"Vermeulen","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drup.2024.101125_bib157","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.redox.2017.08.002","article-title":"Tetrahydrobiopterin in antenatal brain hypoxia-ischemia-induced motor impairments and cerebral palsy","volume":"13","author":"Vasquez-Vivar","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2024.101125_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101407","article-title":"Neuronal vulnerability to fetal hypoxia-reoxygenation injury and motor deficit development relies on regional brain tetrahydrobiopterin levels","volume":"29","author":"Vasquez-Vivar","year":"2020","journal-title":"Redox Biol."},{"issue":"1-3","key":"10.1016\/j.drup.2024.101125_bib159","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/ars.2021.0136","article-title":"Tetrahydrobiopterin in cell function and death mechanisms","volume":"37","author":"Vasquez-Vivar","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib160","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","article-title":"Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF","volume":"116","author":"Wan","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.drup.2024.101125_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101041","article-title":"The promising role of tumor-associated macrophages in the treatment of cancer","volume":"73","author":"Wang","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2024.101125_bib162","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.18632\/aging.103598","article-title":"Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib163","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1142\/S0192415X20500354","article-title":"Cinobufacini inhibits colon cancer invasion and metastasis via suppressing Wnt\/\u03b2-catenin signaling pathway and EMT","volume":"48","author":"Wang","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.drup.2024.101125_bib164","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2646148","article-title":"Epithelial-mesenchymal transition in pancreatic cancer: a review","volume":"2017","author":"Wang","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"20","key":"10.1016\/j.drup.2024.101125_bib165","doi-asserted-by":"crossref","first-page":"12270","DOI":"10.3390\/ijms232012270","article-title":"Lysyl oxidase family proteins: prospective therapeutic targets in cancer","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib166","first-page":"1499","article-title":"REV-ERB\u03b1 reduction is associated with clinicopathological features and prognosis in human gastric cancer.","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2024.101125_bib167","article-title":"Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib168","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/1535-7163.MCT-20-0316","article-title":"EMT-induced gemcitabine resistance in pancreatic cancer involves the functional loss of equilibrative nucleoside transporter 1","volume":"20","author":"Weadick","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2024.101125_bib169","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-019-1092-4","article-title":"LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K\/AKT\/MYC pathway","volume":"38","author":"Wei","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","article-title":"Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments","volume":"20","author":"Wei","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib171","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40169-019-0237-6","article-title":"The role of liver microenvironment in hepatic metastasis","volume":"8","author":"Williamson","year":"2019","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.drup.2024.101125_bib172","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib173","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10620-020-06183-9","article-title":"Dilemma and challenge of immunotherapy for pancreatic cancer","volume":"66","author":"Wu","year":"2021","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib174","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41467-022-28492-5","article-title":"Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications","volume":"13","author":"Xia","year":"2022","journal-title":"Nat. Commun."},{"issue":"14","key":"10.1016\/j.drup.2024.101125_bib175","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.7150\/ijbs.73438","article-title":"SNHG16 upregulation-induced positive feedback loop with YAP1\/TEAD1 complex in Colorectal Cancer cell lines facilitates liver metastasis of colorectal cancer by modulating CTCs epithelial-mesenchymal transition","volume":"18","author":"Xiang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.drup.2024.101125_bib176","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10237-016-0839-5","article-title":"Effects of flowing RBCs on adhesion of a circulating tumor cell in microvessels","volume":"16","author":"Xiao","year":"2017","journal-title":"Biomech. Model Mechanobiol."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib177","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","article-title":"Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment","volume":"71","author":"Xie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.drup.2024.101125_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101002","article-title":"Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs","volume":"71","author":"Xing","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drup.2024.101125_bib179","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13046-018-0974-1","article-title":"Transmembrane protein GRINA modulates aerobic glycolysis and promotes tumor progression in gastric cancer","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib180","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1078-0432.CCR-14-2779","article-title":"Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients","volume":"21","author":"Yaeger","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.drup.2024.101125_bib181","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s10120-015-0579-8","article-title":"Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination","volume":"19","author":"Yamaguchi","year":"2016","journal-title":"Gastric Cancer"},{"issue":"15","key":"10.1016\/j.drup.2024.101125_bib182","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.7150\/jca.44215","article-title":"IL-8 mediates a positive loop connecting increased neutrophil extracellular traps (NETs) and colorectal cancer liver metastasis","volume":"11","author":"Yang","year":"2020","journal-title":"J. Cancer"},{"issue":"14","key":"10.1016\/j.drup.2024.101125_bib183","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2024.101125_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100883","article-title":"Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA","volume":"65","author":"Ye","year":"2022","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13046-019-1074-6","article-title":"MicroRNA-7 as a potential therapeutic target for aberrant NF-\u03baB-driven distant metastasis of gastric cancer","volume":"38","author":"Ye","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib186","first-page":"287","article-title":"Immune regulatory networks and therapy of \u03b3\u03b4 T cells in liver cancer: recent trends and","volume":"12","author":"Yin","year":"2024","journal-title":"Adv. J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2024.101125_bib188","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00262-020-02598-5","article-title":"Activated Hif1a of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer","volume":"69","author":"Yu","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.drup.2024.101125_bib189","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41419-019-1685-z","article-title":"MIR17HG-miR-18a\/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt\/\u03b2-catenin signalling","volume":"10","author":"Yuan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-019-1065-4","article-title":"METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer","volume":"18","author":"Yue","year":"2019","journal-title":"Mol. Cancer"},{"issue":"18","key":"10.1016\/j.drup.2024.101125_bib191","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2024.101125_bib192","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2019.04.002","article-title":"Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer","volume":"454","author":"Zhai","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2024.101125_bib193","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"60","key":"10.1016\/j.drup.2024.101125_bib194","doi-asserted-by":"crossref","first-page":"101760","DOI":"10.18632\/oncotarget.21667","article-title":"MiR-92a promotes stem cell-like properties by activating Wnt\/\u03b2-catenin signalin colorectal cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2024.101125_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.drup.2024.101125_bib196","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.923867","article-title":"A population-based analysis of distant metastasis in stage iv gastric cancer","volume":"26","author":"Zhang","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib197","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbrc.2018.12.177","article-title":"Long non-coding RNA FAM84B-AS promotes resistance of gastric cancer to platinum drugs through inhibition of FAM84B expression","volume":"509","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2024.101125_bib198","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12858-016-0075-8","article-title":"Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Biochem"},{"key":"10.1016\/j.drup.2024.101125_bib199","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-018-0898-6","article-title":"Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2024.101125_bib200","article-title":"Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.drup.2024.101125_bib201","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/BJ20131535","article-title":"miR-30b regulates migration and invasion of human colorectal cancer via SIX1","volume":"460","author":"Zhao","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.drup.2024.101125_bib202","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1081585","article-title":"Emerging mechanisms progress of colorectal cancer liver metastasis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.drup.2024.101125_bib203","article-title":"Observation of tumor-associated macrophages expression in gastric cancer and its clinical pathological relationship","volume":"99","author":"Zhu","year":"2020","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.drup.2024.101125_bib204","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.gastro.2018.10.054","article-title":"Long Noncoding RNA GMAN, Up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of Ephrin A1 by competitively binding GMAN-AS","volume":"156","author":"Zhuo","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T15:25:52Z","timestamp":1731079552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":204,"alternative-id":["S1368764624000839"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101125","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101125"}}